Sort
23,748 grants matching “melanoma”
An integrated functional proteomics platform for accelerated discovery of isoform-specific determinants of cancer
$396,073Gloria Sheynkman · University Of Virginia · R33 · FY2025 · CA
Induction of cytotoxic T cells by pulmonary dendritic cells
$396,023Claudia V Jakubzick · National Jewish Health · R01 · FY2016 · HL
Understanding Resistance to Next Generation Antiandrogens
$396,018Charles L Sawyers · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Induction of cytotoxic T cells by pulmonary dendritic cells
$396,016Claudia V Jakubzick · National Jewish Health · R01 · FY2017 · HL
Development of IDO PET agents for immunotherapy
$396,007Zibo Li · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA
Development of IDO PET agents for immunotherapy
$396,007Zibo Li · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA
Nanowaveguide Illuminated Fluorescence Spectroscopy for Studying Membrane Protein Dynamics
$396,000Zhe-Sheng Chen · St. John'S University · R15 · FY2015 · GM
Role of Polo-Like Kinase-1 in Melanocytic Transformation
$395,886Nihal Ahmad · University Of Wisconsin-Madison · R01 · FY2017 · AR
Development of murine glioblastoma model for oncolytic HSV therapy
$395,812Balveen Kaur · Augusta University · R61 · FY2024 · NS
Project 3: Efficacy of MEK Inhibition in Juvenile Myelomonocytic Leukemia
$395,809Kevin M Shannon · Indiana University Indianapolis · U54 · FY2019 · CA
THE KINOME OF GNAQ/11-MUTANT UVEAL MELANOMA. NEW AWARD.
$395,778Thomas Jefferson University · · FY2020 · Defense Health Agency
Experimental Transformation of Human Melanocytes in Vivo
$395,692Wistar Institute · R01 · FY2004 · CA
Development of a tumor-retentive immunostimulant as adjunct therapy for solid tumor cancers
$395,595Marcus Laird Forrest · Kinimmune, Inc. · R41 · FY2022 · CA
DNA Repair, Skin Cancer and Overall Cancer Risk
$395,550Anthony J Alberg · Medical University Of South Carolina · R01 · FY2009 · CA
Targeting the SKP2 Axis for Anti-melanoma Therapy
$395,509Hiroyuki Inuzuka · Beth Israel Deaconess Medical Center · R01 · FY2025 · CA
Differential role of different NAD+ kinase Isoforms in melanoma metastasis-Relinquishment
$395,509Elena Piskounova · Beth Israel Deaconess Medical Center · R01 · FY2025 · CA
Role of melanoma-PD-1 in cancer progression
$395,502Tobias Schatton · Brigham And Women'S Hospital · R01 · FY2020 · CA
Role of melanoma-PD-1 in cancer progression
$395,502Tobias Schatton · Brigham And Women'S Hospital · R01 · FY2021 · CA
Role of melanoma-PD-1 in cancer progression
$395,502Tobias Schatton · Brigham And Women'S Hospital · R01 · FY2017 · CA
Role of melanoma-PD-1 in cancer progression
$395,501Tobias Schatton · Brigham And Women'S Hospital · R01 · FY2018 · CA
The role of structural variation in promotion, evolution and treatment of various tumor types
$395,435Mikhail Kolmogorov · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
An In Situ Patient-specific Chemo-Immunotherapy for Skin Cancers
$395,401Louis D Falo · University Of Pittsburgh At Pittsburgh · P50 · FY2016 · CA
Localizing Immunotherapy to Improve Therapeutic Index
$395,388Karl D Wittrup · Massachusetts Institute Of Technology · R01 · FY2016 · CA
Localizing Immunotherapy to Improve Therapeutic Index
$395,388Karl D Wittrup · Massachusetts Institute Of Technology · R01 · FY2015 · CA
Localizing Immunotherapy to Improve Therapeutic Index
$395,388Karl D Wittrup · Massachusetts Institute Of Technology · R01 · FY2013 · CA